Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid-Derived Suppressor Cells and Radiotherapy
Carlos Jiménez‐Cortegana, Claudia Galassi, Vanessa Klapp, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 5, pp. 545-557
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 177
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy
Liangliang Wang, Xiaoyang Dou, Shijie Chen, et al.
Cancer Cell (2023) Vol. 41, Iss. 7, pp. 1294-1308.e8
Open Access | Times Cited: 105
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 100
Type I interferon and cancer
Peter Holíček, Emma Guilbaud, Vanessa Klapp, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 115-127
Open Access | Times Cited: 45
Radiotherapy and immunology
Liangliang Wang, Connor Lynch, Sean P. Pitroda, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Open Access | Times Cited: 28
Radiotherapy, immunity, and immune checkpoint inhibitors
Connor Lynch, Sean P. Pitroda, Ralph R. Weichselbaum
The Lancet Oncology (2024) Vol. 25, Iss. 8, pp. e352-e362
Closed Access | Times Cited: 22
“Reinforcement” by Tumor Microenvironment: The Seventh “R” of Radiobiology
Farzad Taghizadeh‐Hesary
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 119, Iss. 3, pp. 727-733
Closed Access | Times Cited: 26
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
Yuzhu Hou, Kaiting Yang, Liangliang Wang, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1945-1958
Open Access | Times Cited: 11
Multiple cancer cell types release LIF and Gal3 to hijack neural signals
Qun Xu, Ying Cao, Fanni Kong, et al.
Cell Research (2024) Vol. 34, Iss. 5, pp. 345-354
Open Access | Times Cited: 11
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Elena Catanzaro, Manuel Beltrán‐Visiedo, Lorenzo Galluzzi, et al.
Cellular and Molecular Immunology (2024)
Open Access | Times Cited: 11
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N. Donahue, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer
Pengyu Yao, Liang Su, Zhenying Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Optimized CAR-T therapy based on spatiotemporal changes and chemotactic mechanisms of MDSCs induced by hypofractionated radiotherapy
Benxia Zhang, Min Hu, Qizhi Ma, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 2105-2119
Open Access | Times Cited: 14
Translational Frontiers and Clinical Opportunities of Immunologically Fitted Radiotherapy
Daphné Morel, Charlotte Robert, Nikos Paragios, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 11, pp. 2317-2332
Open Access | Times Cited: 6
The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Gabriel Cabrera, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?
Sofian Benkhaled, Cedric Peters, Nicolas Jullian, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 768-768
Open Access | Times Cited: 13
Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance
Liangliang Wang, Wei Si, Xianbin Yu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 24
Open Access | Times Cited: 12
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells
Xinyu Tian, Ting Wang, Han Shen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 108-121
Closed Access | Times Cited: 11
Liposome-based nanomedicine for immune checkpoint blocking therapy and combinatory cancer therapy
Haoyuan Zhou, Cui‐Yun Yu, Hua Wei
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123818-123818
Closed Access | Times Cited: 4
The effect of radiation treatment of solid tumors on neutrophil infiltration and function: a systematic review
Léon Raymakers, Thijs J. Demmers, Gert J. Meijer, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 3, pp. 845-861
Open Access | Times Cited: 4
The Proimmunomodulatory and Anti-immunomodulatory Effects of Radiotherapy in Oncologic Care
Bryan Johnson, Qianyu Guo, Keyur Chaludiya, et al.
Hematology/Oncology Clinics of North America (2025)
Closed Access
Distinct immune responses to proton and photon radiotherapy: implications for anti-PD-L1 combination therapy in colorectal cancer
Hélène Burckel, Anaïs Nicol, Carole Mura, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Reengineering the Tumor Oxygen Microenvironment in Radiotherapy to Enhance T‐Cell Function for Radio‐Immunotherapy
Zetong Chen, Qing‐Yu He, Rui Qian, et al.
Advanced Functional Materials (2025)
Closed Access
Impact of radiation therapy on the immunological tumor microenvironment
Emma Guilbaud, Flavie Naulin, Lydia Meziani, et al.
Cell chemical biology (2025)
Closed Access
Page 1 - Next Page

Scroll to top